Performance Data Summary1

 

Economic Contribution 2012/132013/142014/15
Economic value generatedUS$million5,1305,5245,628
Economic value distributed US$million 4,713 4,9565,009
read more >>
Research and Development 2012/132013/142014/15
R&D InvestmentUS$million427466463
read more >>
Safety and Quality 2012/132013/142014/15
Regulatory auditsNumber189179263
Quality audits of suppliersNumber512435497
Safety related recalls of finished productNumber323
read more >>
Our People 2012/132013/142014/15
Total headcountNumber12,53413,46814,874
Employee opinion survey participation rate%65--
Lost time injury frequency rate (LTIFR)Per million hours worked1.801.430.75
Medical treatment injury frequency rate (MTIFR)Per million hours worked6.605.776.22
Days lost frequency rate (DLFR)Per million hours worked40.928.3617.82
Serious injury/illness frequency rate (SIIFR)Per million hours worked-0.520.24
read more >>
Community 2012/132013/142014/15
Total contributionUS$million36.332.828.4
read more >>
Environment 2012/132013/142014/15
Energy consumptionPetajoules2.032.252.43
Greenhouse gas emissionsKilotonnes201223239
Water consumptionGigalitres2.302.602.69
WasteKilotonnes19.9120.2621.83
Waste recycling rate%585964
read more >>

1 Data does not include CSL’s acquisition of Novartis’ influenza vaccine business.
More information, including data points from baseline years, is available on our website - csl.com.au



View our Performance Summary.